Evoke Pharma, Inc. total revenue, net income and dynamics of changes in US dollar today
Evoke Pharma, Inc. current income in US dollar. Net revenue of Evoke Pharma, Inc. on 31/03/2021 amounted to 90 421 $. Net income of Evoke Pharma, Inc. today amounted to -2 605 495 $. The value of "net income" Evoke Pharma, Inc. on the graph is displayed in blue. All information on Evoke Pharma, Inc. total revenue on this chart is created in the form of yellow bars. The value of all Evoke Pharma, Inc. assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
90 421 $
-
-2 605 495 $
-
31/12/2020
23 020 $
-
-2 267 862 $
-
30/09/2020
0 $
-
-2 129 105 $
-
30/06/2020
0 $
-
-6 967 395 $
-
31/03/2019
0 $
-
-1 965 266 $
-
31/12/2018
0 $
-
-1 760 632 $
-
30/09/2018
0 $
-
-1 519 468 $
-
30/06/2018
0 $
-
-2 303 193 $
-
31/03/2018
0 $
-
-1 982 786 $
-
31/12/2017
0 $
-
-308 443 $
-
30/09/2017
0 $
-
-5 243 061 $
-
30/06/2017
0 $
-
-1 625 969 $
-
Show:
to
Evoke Pharma, Inc. financial report charts
Dates of Evoke Pharma, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Evoke Pharma, Inc. is 31/03/2021. Gross profit Evoke Pharma, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Evoke Pharma, Inc. is 25 670 $
Evoke Pharma, Inc. quarterly report dates
Cost of revenue Evoke Pharma, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Evoke Pharma, Inc. is 64 751 $ Total revenue Evoke Pharma, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Evoke Pharma, Inc. is 90 421 $ Operating income Evoke Pharma, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Evoke Pharma, Inc. is -2 590 450 $
Net income Evoke Pharma, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Evoke Pharma, Inc. is -2 605 495 $ Current assets Evoke Pharma, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Evoke Pharma, Inc. is 19 176 024 $ Total assets Evoke Pharma, Inc. refers to the total amount of assets owned by a person or entity. Total assets Evoke Pharma, Inc. is 19 295 950 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
25 670 $
-63 692 $
-
-
-
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
64 751 $
86 712 $
-
-
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
90 421 $
23 020 $
-
-
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-2 590 450 $
-2 209 086 $
-2 079 610 $
-6 964 966 $
-1 969 895 $
-1 768 420 $
-1 522 557 $
-2 306 096 $
-2 417 611 $
-2 659 134 $
-3 701 745 $
-2 889 548 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-2 605 495 $
-2 267 862 $
-2 129 105 $
-6 967 395 $
-1 965 266 $
-1 760 632 $
-1 519 468 $
-2 303 193 $
-1 982 786 $
-308 443 $
-5 243 061 $
-1 625 969 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
277 825 $
103 846 $
205 032 $
5 782 094 $
746 882 $
695 360 $
625 497 $
1 388 791 $
1 385 366 $
1 631 540 $
2 717 698 $
2 017 569 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 680 871 $
2 232 106 $
2 079 610 $
6 964 966 $
1 969 895 $
1 768 420 $
1 522 557 $
2 306 096 $
2 417 611 $
2 659 134 $
3 701 745 $
2 889 548 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
19 176 024 $
9 280 792 $
6 714 784 $
8 195 845 $
4 259 580 $
5 648 222 $
7 006 875 $
6 626 312 $
5 584 859 $
7 930 313 $
10 747 696 $
13 144 212 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
19 295 950 $
9 434 048 $
6 750 899 $
8 267 056 $
4 362 832 $
5 659 773 $
7 018 426 $
6 626 312 $
5 584 859 $
7 941 864 $
10 759 247 $
13 155 763 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
18 185 974 $
8 068 939 $
6 280 656 $
7 990 392 $
4 028 550 $
5 319 004 $
6 567 918 $
6 531 079 $
5 405 944 $
7 679 267 $
10 412 968 $
12 556 280 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
1 287 387 $
1 634 453 $
1 610 677 $
1 265 934 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
5 405 944 $
7 679 267 $
10 412 968 $
12 556 280 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
1 287 387 $
1 634 453 $
1 610 677 $
1 265 934 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
29.51 %
28.88 %
22.95 %
19.10 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
7 811 384 $
-3 214 623 $
-1 923 415 $
-373 676 $
3 075 445 $
4 025 320 $
5 407 749 $
5 360 378 $
4 389 266 $
2 165 749 $
2 059 687 $
6 769 989 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-1 926 886 $
-1 248 914 $
-1 149 938 $
-1 761 742 $
-2 817 966 $
-2 733 701 $
-2 200 174 $
-2 096 218 $
Last revenue report of Evoke Pharma, Inc. was 31/03/2021. According to last financial report total revenue in Evoke Pharma, Inc. was 90 421 US dollar and changed by 0% since last year. Net income in Evoke Pharma, Inc. was -2 605 495 $ in last quartal, net income changes to 0%.
Current cash Evoke Pharma, Inc. - the sum of all of the cash a company has on the date of report. Current cash Evoke Pharma, Inc. is 18 185 974 $
Evoke Pharma, Inc. stocks data
EVOK stock price
Evoke Pharma, Inc. stock price today, EVOK stock quote.
